--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 8, 20242024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
May 10, 20242024/Q10.000 / 0.000--
MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
MBRX Moleculin Biotech
- 1.6700
- -0.1400-7.73%
Close Dec 20 16:00 ET
- 1.6700
- 0.00000.00%
Post 20:01 ET
5.33MMarket Cap-0.14P/E (TTM)
1.8900High1.6700Low59.29KVolume1.8000Open1.8100Pre Close104.00KTurnover2.13%Turnover RatioLossP/E (Static)3.19MShares15.750052wk High0.71P/B4.66MFloat Cap1.670052wk Low--Dividend TTM2.79MShs Float731.7000Historical High--Div YieldTTM12.16%Amplitude1.6700Historical Low1.7540Avg Price1Lot Size
Moleculin Biotech Key Stats
Moleculin Biotech Q3 2024 Earnings Date
Currency：USDNov 8, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 0 | 0 | 0 |
-- | -- | -- | |
| EPS | -2.44 | -2.85 | -0.41 |
| Miss Est. | +14.39% | -1.06% | -16.81% |
Analyst Rating
Nov 12, 2024
Moleculin Biotech Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Moleculin Biotech Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data